Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9457
Title: | Antibacterial and DNA-based hydrogels in situ block TNF-alpha to promote diabetic alveolar bone rebuilding |
Authors: | Peng, L.;Li, W.;Peng, G.;Wei, D.;Gou, L.;Zhou, Y.;Zhou, Y.;Chen, X.;Wu, L.;Zhang, W.;Hu, L.;Cao, Qi;Wang, C.;Zhang, Y. |
WSLHD Author: | Cao, Qi |
Subjects: | Diabetes |
Issue Date: | 2024 |
Citation: | Macromolecular rapid communications 45(5):e2300559, 2024 |
Abstract: | Alveolar bone injury under diabetic conditions can severely impede many oral disease treatments. Rebuilding diabetic alveolar bone in clinics is currently challenging due to persistent infection and inflammatory response. Here, we develop an antibacterial DNA-based hydrogel named Agantigel by integrating silver nanoclusters (AgNCs) and tumor necrosis factor-alpha (TNF-alpha) antibody into DNA hydrogel to promote diabetic alveolar bone regeneration. Agantigel can effectively inhibit bacterial growth through AgNCs while exhibiting negligible cytotoxicity in vitro. The sustained release of TNF-alpha antibody from Agantigel effectively blocks TNF-alpha and promotes M2 polarization of macrophages, ultimately accelerating diabetic alveolar bone regeneration in vivo. After 21 days of treatment, Agantigel significantly accelerates the defect healing rate of diabetic alveolar bone up to 82.58 +/- 8.58% and improves trabecular architectures compared to free TNF-alpha (42.52 +/- 15.85%). Our results imply that DNA hydrogels are potential bio-scaffolds helping the sustained release of multidrug for treating DABI or other oral diseases. |
URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9457 |
DOI: | https://dx.doi.org/10.1002/marc.202300559 |
Journal: | Macromolecular rapid communications |
Type: | Journal Article |
Study or Trial: | Prospective Study |
Department: | Nephrology |
Facility: | Westmead |
Affiliated Organisations: | West China Hospital, Sichuan University, Chengdu, China Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, NSW, Sydney, Australia |
Keywords: | Hydrogels Tumor necrosis factor-alpha diabetes Mellitus antibacterial agents |
Appears in Collections: | Westmead Hospital 2019 - 2024 |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.